Virax Biolabs Group Limited (VRAX) Financials

NASDAQ Currency in USD Disclaimer

$1.72

south_east -$0.2 (-10.42%)
Day's range
$1.62
Day's range
$1.87

VRAX Income statement / Annual

Last year (2024), Virax Biolabs Group Limited's total revenue was $156,419.00, an increase of 1,727.11% from the previous year. In 2024, Virax Biolabs Group Limited's net income was -$6.73 M. See Virax Biolabs Group Limited�s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 03/31/2024 03/31/2023 03/31/2022 03/31/2021 03/31/2020
Operating Revenue $156,419.00 $8,561.00 $0.00 $123,820.00 $99,876.00
Cost of Revenue $105,829.00 $9,926.00 $0.00 $133,254.00 $54,127.00
Gross Profit $50,590.00 -$1,365.00 $0.00 -$9,434.00 $45,749.00
Gross Profit Ratio 0.32 -0.16 0 -0.08 0.46
Research and Development Expenses $1.56 M $397,109.00 $433,743.00 $120,221.00 $87,000.00
General & Administrative Expenses $4.59 M $5.31 M $1.29 M $457,680.00 $602,303.00
Selling & Marketing Expenses $0.00 $26,616.00 $13,818.00 $57,203.00 $7,690.00
Selling, General & Administrative Expenses $4.59 M $5.33 M $1.30 M $514,883.00 $609,993.00
Other Expenses $390,355.00 $290,466.00 $0.00 $266.00 $2,470.00
Operating Expenses $6.55 M $5.73 M $1.73 M $635,104.00 $696,993.00
Cost And Expenses $6.65 M $5.74 M $1.73 M $768,358.00 $751,120.00
Interest Income $0.00 $15,468.00 $15,438.00 $28,643.00 $90,690.00
Interest Expense $26,878.00 $15,468.00 $15,438.00 $28,643.00 $90,690.00
Depreciation & Amortization $103,099.00 $1.00 $1.73 M $644,538.00 $651,244.00
EBITDA -$6.61 M -$5.44 M -$750.00 $0.00 -$648,774.00
EBITDA Ratio -42.25 -669.64 0 -5.21 -6.5
Operating Income Ratio -41.53 -669.64 0 -5.21 -6.52
Total Other Income/Expenses Net -$242,647.00 $274,998.00 -$16,191.00 -$28,377.00 -$88,220.00
Income Before Tax -$6.74 M -$5.46 M -$1.75 M -$672,915.00 -$739,464.00
Income Before Tax Ratio -43.08 -637.51 0 -5.43 -7.4
Income Tax Expense $0.00 -$271.00 -$1.77 M -$666,469.00 $61,667.00
Net Income -$6.73 M -$5.46 M -$1.71 M -$650,984.00 -$801,131.00
Net Income Ratio -43.05 -637.48 0 -5.26 -8.02
EPS -3.36 -5.13 -1.5 -0.57 -0.7
EPS Diluted -3.36 -5.13 -1.5 -0.57 -0.7
Weighted Average Shares Out $2.01 M $1.06 M $1.14 M $1.14 M $1.14 M
Weighted Average Shares Out Diluted $2.01 M $1.06 M $1.14 M $1.14 M $1.14 M
Link